Sarabia, Naomi A.

HRN: 26-09-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/21/2024
11/27/2024
IV
600mg
Q6
Debridement Left Leg
Waiting Final Action 
11/24/2024
CLINDAMYCIN 300MG (CAP)
11/24/2024
12/01/2024
PO
300mg
TID
S/P Wound Debridement
Waiting Final Action 
11/24/2024
AZITHROMYCIN 500MG TABLET (TAB)
11/24/2024
11/28/2024
PO
500mg
OD
Cap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: